NCT07137195 2026-02-27
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)
Ion Beam Applications
Phase NA Active not recruiting
Clinical Trials
12 trialsNCT06397963 2026-01-26
Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours
Grit Biotechnology
Phase NA Recruiting
NCT07153094 2026-01-16
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)
Ion Beam Applications
Phase NA Active not recruiting
NCT07152353 2026-01-07
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan)
Ion Beam Applications
Phase NA Active not recruiting
NCT06658951 2025-04-16
Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
Phase NA Recruiting
NCT06889675 2025-03-21
First in Human Study of YB1-X7 Injection
Shanghai Salvectors Biotechnology LTD.
Phase NA Not yet recruiting
NCT06145802 2025-02-17
Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (gynecological Tumors)
Grit Biotechnology
Phase NA Recruiting
NCT06245018 2024-02-07
A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor
Nuwacell Biotechnologies Co., Ltd.
Phase NA Not yet recruiting
NCT05949775 2023-07-18
Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors
Stemirna Therapeutics
Phase NA Not yet recruiting
NCT03998345 2020-09-09
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase NA Unknown
NCT01369433 2020-09-01
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
AVEO Pharmaceuticals, Inc.
Phase NA Terminated
NCT00798889 2013-01-21
Rollover Protocol for Prior SU011248 Protocols
Pfizer
Phase NA Completed